Suubi+Adherence for HIV treatment in Ugandan youth
Official title: Suubi+Adherence4Youth: Optimizing the Suubi Intervention for Adherence to HIV Treatment for Youth Living with HIV in Uganda
Funded at New York University · NIH-11507674 · Data updated 2026-11-12
A study in Uganda tests how different parts of a support program for young people with HIV affect sticking to their ART and staying healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 1, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $305,820 |
| NIH project number | 7R01MH131507-05 |
| Project ID | NIH-11507674 on NIH RePORTER |
Who could benefit from this research
✓Could help
Aging with HIV adolescents in Uganda who are in care and eligible for ART.
✕Less likely to help
Patients not enrolled in ART or not in care at participating sites may not benefit.
What this research studies
This project will test a multi-component program called Suubi to see which parts help Ugandan adolescents with HIV take their medicines and keep viral loads under control. It uses a factorial design to mix components like financial literacy, savings accounts with incentives, adherence/stigma support, and peer role models to see how they work together. The goal is to figure out which combination is most effective and whether fewer components could work as well. The study builds on previous Suubi trials that showed benefits in adherence and well-being. It focuses on real patients, in real clinics, over several years.
Why it matters
Potential benefit: If successful, the findings could guide more effective, scalable support for ALHIV to improve adherence and health outcomes.
How similar studies have gone: Prior Suubi trials showed robust positive effects on adherence and viral suppression.
Where this research is happening
-
New York University
New York, United States Active
Researchers
- Principal investigator: Ssewamala, Fred M — New York University
- Study coordinator: Ssewamala, Fred M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.